Self Tests
Disorders and Treatment
- Mental Illness
- Depression
- Bipolar Disorder
- Mood Disorders
- Borderline Personality
- Schizophrenia
- Anxiety
- Mental Health Diagnosis
- Mental Health Treatments
- Alternative Meds
- Case Studies
Aripiprazole (Abilify®) is prescribed for symptoms of schizophrenia in persons 13 years of age and older. It is also used alone or as an add-on to treat co-occurring symptoms of mania and depression in adults, teenagers, and children 10 years of age and older who have bipolar disorder.
Aripiprazole is also used as an add-on with an antidepressant to treat depression when symptoms cannot be controlled by the antidepressant alone. Aripiprazole is prescribed for treament of children 6 to 17 years of age who have autistic disorder.
Aripiprazole is an atypical antipsychotic - a class of drugs that changes neural activity.
Aripiprazole may cause side effects. Consult your doctor if any of these symptoms become severe or persistent:
Some side effects are more serious than others. The following symptoms require immediate medical attention:
Aripiprazole may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
The information provided on the PsyWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of PsyWeb.com nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.